Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Abraham Rubinstein

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
Anti-Cancer Drugs|August 19, 2006
Celecoxib can induce cell death independently of cyclooxygenase-2, p53, Mdm2, c-Abl and reactive oxygen speciesSue Haupt, Jackie Kleinstern, Ygal Haupt, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 12, 2005
Targeting normal and neoplastic tissues in the rat jejunum and colon with boronated, cationic acrylamide copolymersAbdel-Kareem Azab, Morris Srebnik, Victoria Doviner, et al.
Chemical Reviews|April 24, 2012
Boron containing compounds as protease inhibitorsReem Smoum, Abraham Rubinstein, Valery M Dembitsky, et al.
Pharmaceutical Research|October 26, 2007
The metastatic stage-dependent mucosal expression of sialic acid is a potential marker for targeting colon cancer with cationic polymersAbdel Kareem Azab, Jackie Kleinstern, Morris Srebnik, et al.
European Journal of Cancer (Oxford, England : 1990)|December 23, 2003
Design of a multivalent galactoside ligand for selective targeting of HPMA copolymer-doxorubicin conjugates to human colon cancer cellsA David, P Kopecková, Tamara Minko, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|October 1, 2018
Synchronizing the release rates of salicylate and indomethacin from degradable chitosan hydrogel and its optimization by definitive screening designRacheli Sharon Gabbay, Ron S Kenett, Roberto Scaffaro, et al.
Bioorganic & Medicinal Chemistry Letters|October 5, 2010
Aminoalkylcarbamoylphosphonates reduce TNFα release from activated immune cellsEfrat Harel, Abraham Rubinstein, Weibin Chen, et al.
Molecular Pharmaceutics|February 1, 2012
Detection of endogenous K-ras mRNA in living cells at a single base resolution by a PNA molecular beaconYossi Kam, Abraham Rubinstein, Aviram Nissan, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|April 4, 2006
Luminal delivery and dosing considerations of local celecoxib administration to colorectal cancerSue Haupt, Tamar Zioni, Irith Gati, et al.
Journal of Drug Targeting|June 7, 2006
Local treatment of experimental colitis in the rat by negatively charged liposomes of catalase, TMN and SODTareq Taha Jubeh, Mirela Nadler-Milbauer, Yechezkel Barenholz, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
Anti-Cancer Drugs|August 19, 2006
Celecoxib can induce cell death independently of cyclooxygenase-2, p53, Mdm2, c-Abl and reactive oxygen speciesSue Haupt, Jackie Kleinstern, Ygal Haupt, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 12, 2005
Targeting normal and neoplastic tissues in the rat jejunum and colon with boronated, cationic acrylamide copolymersAbdel-Kareem Azab, Morris Srebnik, Victoria Doviner, et al.
Chemical Reviews|April 24, 2012
Boron containing compounds as protease inhibitorsReem Smoum, Abraham Rubinstein, Valery M Dembitsky, et al.
Pharmaceutical Research|October 26, 2007
The metastatic stage-dependent mucosal expression of sialic acid is a potential marker for targeting colon cancer with cationic polymersAbdel Kareem Azab, Jackie Kleinstern, Morris Srebnik, et al.
European Journal of Cancer (Oxford, England : 1990)|December 23, 2003
Design of a multivalent galactoside ligand for selective targeting of HPMA copolymer-doxorubicin conjugates to human colon cancer cellsA David, P Kopecková, Tamara Minko, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|October 1, 2018
Synchronizing the release rates of salicylate and indomethacin from degradable chitosan hydrogel and its optimization by definitive screening designRacheli Sharon Gabbay, Ron S Kenett, Roberto Scaffaro, et al.
Bioorganic & Medicinal Chemistry Letters|October 5, 2010
Aminoalkylcarbamoylphosphonates reduce TNFα release from activated immune cellsEfrat Harel, Abraham Rubinstein, Weibin Chen, et al.
Molecular Pharmaceutics|February 1, 2012
Detection of endogenous K-ras mRNA in living cells at a single base resolution by a PNA molecular beaconYossi Kam, Abraham Rubinstein, Aviram Nissan, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|April 4, 2006
Luminal delivery and dosing considerations of local celecoxib administration to colorectal cancerSue Haupt, Tamar Zioni, Irith Gati, et al.
Journal of Drug Targeting|June 7, 2006
Local treatment of experimental colitis in the rat by negatively charged liposomes of catalase, TMN and SODTareq Taha Jubeh, Mirela Nadler-Milbauer, Yechezkel Barenholz, et al.
Pageof 4